Preclinical systemic toxicity evaluation of chitosan-solid–lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice
Arvind Thakkar,1 Sushma Chenreddy,1 Astrid Thio,1 Wael Khamas,2 Jeffrey Wang,1 Sunil Prabhu1 1Department of Pharmaceutical Sciences, College of Pharmacy, 2College of Veterinary Medicine, Western University of Health Sciences, Pomona, CA, USA Abstract: Our previous studies have established the effi...
Guardado en:
Autores principales: | Thakkar A, Chenreddy S, Thio A, Khamas W, Wang J, Prabhu S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94ab8fee00204a259e57bfa9e5b78417 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
por: Tsai WH, et al.
Publicado: (2018) -
Cytotoxicity Effects of Curcumin Loaded on Chitosan Alginate Nanospheres on the KMBC-10 Spheroids Cell Line
por: Afzali E, et al.
Publicado: (2021) -
Studies on statistical optimization of sulforaphane production from broccoli seed
por: Wu,Yuanfeng, et al.
Publicado: (2013) -
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
por: Loutfy SA, et al.
Publicado: (2020) -
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
por: Loutfy SA, et al.
Publicado: (2021)